Cambridge Investment Research Advisors, Inc. Cortexyme, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Cortexyme, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 15,200 shares of CRTX stock, worth $19,608. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,200Holding current value
$19,608% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRTX
# of Institutions
46Shares Held
8.43MCall Options Held
97KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT2.53MShares$3.26 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.45MShares$1.88 Million0.0% of portfolio
-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
-
Ieq Capital, LLC439KShares$566,6580.0% of portfolio
-
Geode Capital Management, LLC Boston, MA397KShares$512,1060.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M